Global Health Ventures (GHLV.OB) Takes Viagra Head On
Whether it is comfortable “table talk” or not, there are certain aspects of biotechnology stocks, such as anal fissures or sexually transmitted diseases, that produce incredible amounts of revenue each year for the companies behind therapies that treat the given ailment. Erectile dysfunction may not be the most pleasant of conversations for many people, but the bottom line is that Pfizer has generated a great deal of cash since bringing Viagara to market and that reason alone is enough to catch the attention of the investment community. Vancouver, British Columbia-based Global Health, Inc., a specialty pharmaceutical company with expertise in…